Does diacylglycerol kinase alpha enhance hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway?
DGKα is involved in HCC progression by activation of the MAPK pathway. DGKα could be a novel target for HCC therapeutics as well as a prognostic marker.
RF or MW ablation of tumors in liver, kidney, bone and lung can be performed safely in patients with permanent intra-cardiac devices, but careful planning between radiology and cardiology is essential to avoid adverse outcomes.